FDA Inspection 1291844 — Sichuan Guangsong Pharmaceutical Co.,Ltd.
The FDA completed an inspection of Sichuan Guangsong Pharmaceutical Co.,Ltd. on Nov 5, 2025 in Chengdu. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 5, 2025
- Fiscal Year
- 2026
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Chengdu (China)